Ceftriaxone versus cefazolin with probenecid for severe skin and soft tissue infections

Journal of Emergency Medicine

Volumn 14, Issue 5, 1996, Pages 547-551

  Brown, Glen ^a   Chamberlain, Robert ^a   Goulding, Jim ^a   Clarke, Allison ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

cefazolin; ceftriaxone; cellulitis; probenecid

Indexed keywords

CEFAZOLIN; CEFTRIAXONE; PROBENECID;

ANTIBIOTIC THERAPY; ARTICLE; CELLULITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN INFECTION; SOFT TISSUE INFECTION; STATISTICAL ANALYSIS; TREATMENT FAILURE;

EID: 0030250333     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(96)00126-6     Document Type: Article

References (20)

1. 1. Hook EW, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med. 1986;146:295-7.
2. 2. Orangio GR, Pitlick SD, Latta PD, et al. Soft tissue infections in parenteral drug abusers. Ann Surg. 1984;199:97-100.
3. 3. Ginsberg MB. Cellulitis: an analysis of 101 cases and review of the literature. S Med J. 1981;74:530-3.
4. 4. Bradsher RW, Snow RM. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen. Am J Med. 1984:77(4C):63-7.
5. 5. Gordin FM, Wofsy CB, Mills J. Once-daily ceftriaxone for skin and soft tissue infections. Antimicrob Agents Chemother. 1985; 27:648-9.
6. 6. Parish LW, Witkowski JA. Ceforanide compared with cefazolin in skin and soft tissue infections. Cutis. 1984;33:313-19.
7. 7. Fass RJ, Freimer EH, McCloskey RV. Treatment of skin and soft tissue infections with imipenem/cilastatin. Am J Med. 1985; 78(6A):110-12.
8. 8. Slutkin G, Marzouk J, Dall L, Mills J, Comparison of cefonicid and cefazolin for treatment of soft-tissue infections. Rev Inf Dis. 1984;6(Suppl. 4):S853-6.
9. 9. Goldstein NH, Topiel MS, Ehrlich A, Simon G. A compartive study of cetriaxone vs. cefazolin in the treatment of cellulitis. Curr Ther Res. 1984;36:653-7.
10. 10. Brown G, Zemcov SJV, Clarke AM. The effect of probenecid on cefazolin serum concentrations. J Antimicrob Chemother. 1993;31:1009-11.
11. 11. Goto S. The in vitro and in vivo antibacterial activity of cefuroxime. Pro Roy Soc Med. 1977;70(Suppl. 9):56-62.
12. 12. Stoeckel K, Trueb V, Dubach UC, McNamara PJ. Effect of probenecid on the elimination and protein binding of ceftriaxone. Eur J Clin Pharmacol. 1988;34;151-6.
13. 13. Sachs MK. The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. Arch Intern Med. 1990; 150:1907-12.
14. 14. Beaufoy A. Infections in intravenous drug users: a two-year review. Can J Infect Control. 1993;8:7-9.
15. 15. Chirugi VA, Edelstein H, Oster SE, et al. Randomized comparison trial of teicoplanin IV, teicoplanin IM, and cefazolin therapy for skin and soft tissue infections caused by gram-positive bacteria. S Med J. 1994;87:875-80.
16. 16. Edelstein HS, Oster SE, Chirurgi VA, Karp RA, Cassano KB, McCabe RE. Intravenous or intramuscular teicoplanin once daily for skin and soft-tissue infections. DICP, Ann Pharmacother. 1991;25:914-8.
17. 17. Lefrock JL, Mosconi G. Prospective randomized trial of teicoplanin vs. cefazolin for the therapy of skin and skin-structure infections caused by gram-positive bacteria. 35th ICAAC Conference, San Francisco, September, 1995 (Abstract).
18. 18. Brown GR. Cephalosporin-probenecid drug interactions. Clin Pharmacokinet. 1993;24:289-300.
19. 19. Vlasses PH, Holbrook AM, Schrogie JJ, Rogers JD, Ferguson RK, Abrams WB. Effect of orally administered probenecid on the pharmacokinetics of cefoxitin. Antimicrob Agents Chemother. 1980;17:847-55.
20. 20. Cunningham RF, Israili ZH, Dayton PG. Clinical pharmacokinetics of probenecid. Clin Pharmacokinet. 1981;6:135-51.